Lanthionine synthetase C-like 2-based therapeutics

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 9556146
SERIAL NO

14662506

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

Provided are compounds that target the lanthionine synthetase C-like protein 2 pathway. The compounds can be used to treat a number of conditions, including infectious disease, autoimmune disease, diabetes, and a chronic inflammatory disease.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
NIMMUNE BIOPHARMA INC1013 MCBRYDE LANE BLACKSBURG VA 24060

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Bassaganya-Riera, Josep Blacksburg, US 49 187
Carbo, Barrios Adria Blacksburg, US 9 60
Cooper, Julian D Blacksburg, US 14 121
Gandour, Richard Blacksburg, US 9 60
Hontecillas, Raquel Blacksburg, US 39 164

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
11.5 Year Payment $7400.00 $3700.00 $1850.00 Jul 31, 2028
Fee Large entity fee small entity fee micro entity fee
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00